Type Whole antibody Target CD4 CAS Number 652153-01-0 | Source Human ATC code none ChemSpider none | |
How to pronounce zanolimumab
Zanolimumab (expected trade name HuMax-CD4) is a human monoclonal antibody and an immunosuppressive drug. It is being developed for the treatment of rheumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma. The drug is currently undergoing Phase II trials.
References
Zanolimumab Wikipedia(Text) CC BY-SA